Crinetics Pharmaceuticals Inc Sustainability Reports
A commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300Q1CNFXK5P31D28
FIGI: BBG00BC592C3
3 reports from 2020 to 2024
